ALPS Medical Breakthroughs ETF (SBIO)

Add to Watchlists
Create an Alert
35.55 -0.22  -0.61% NYSE Arca Feb 16, 20:00 Delayed 2m USD
View Full Chart
SBIO Price Chart

SBIO Performance

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 5.05% 5.32% 0.61% 11
3M 18.96% 18.86% 7.92% 3
6M 28.05% 28.05% 11.43% 5
YTD 8.42% 8.73% 4.84% 12
1Y 41.88% 41.69% 19.56% 5
3Y 9.88% 9.80% 6.15% 20
5Y -- -- 16.37% --
10Y -- -- 13.00% --
As of Feb. 16, 2018. Returns for periods of 1 year and above are annualized.

SBIO Asset Allocation

Type % Net % Long % Short
Cash 0.03% 0.04% 0.02%
Stock 99.97% 99.97% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of Feb. 16, 2018

SBIO Region Exposure

Americas 88.02%
North America 88.02%
Latin America 0.00%
Greater Europe 11.98%
United Kingdom 4.28%
Europe Developed 7.09%
Europe Emerging 0.00%
Africa/Middle East 0.61%
Greater Asia 0.00%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.00%
% Emerging Markets 0.00%
As of Feb. 16, 2018. Region breakdown data is calculated by using the long position holdings of the portfolio.

SBIO Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 100.0%
Industrials 0.00%
Real Estate 0.00%
Technology 0.00%
Utilities 0.00%
As of Feb. 16, 2018

SBIO Stock Market Capitalization

Giant 0.00%
Large 0.00%
Medium 7.28%
Small 63.84%
Micro 28.88%
As of Feb. 16, 2018

SBIO Stock Style Exposure

Large Cap Value 0.00%
Large Cap Blend 0.00%
Large Cap Growth 0.00%
Mid Cap Value 2.90%
Mid Cap Blend 0.00%
Mid Cap Growth 5.13%
Small Cap Value 8.26%
Small Cap Blend 22.81%
Small Cap Growth 60.90%
As of Feb. 16, 2018
View More Holdings

SBIO Top 10 Holdings

Symbol Name % Weight Price % Chg
BGNE BeiGene Ltd ADR 4.64% 136.64 -0.04%
GLPG Galapagos NV ADR 4.38% 115.33 -1.20%
FGEN FibroGen Inc 3.46% 56.50 +0.09%
SRPT Sarepta Therapeutics Inc 3.09% 64.00 +1.36%
TARO Taro Pharmaceutical Industries Ltd 3.08% 101.60 -0.28%
AKRX Akorn Inc 2.98% 31.85 -0.31%
AGIO Agios Pharmaceuticals Inc 2.80% 77.70 -1.38%
ARRY Array BioPharma Inc 2.50% 16.98 -1.57%
LGND Ligand Pharmaceuticals Inc 2.48% 157.14 -0.03%
GWPH GW Pharmaceuticals PLC ADR 2.48% 131.01 +0.26%
As of Feb. 16, 2018
Advertisement

SBIO One Page Reports

SBIO Basic Info

Style
Equity Style Small Cap/Growth
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Health
Fund Owner Firm Name ALPS
Benchmark Index
Poliwogg Medical Breakthroughs TR USD
100.0%

SBIO Manager Info

Name Tenure
Andrew Hicks 1.59 yrs
Michael Akins 2.84 yrs
Ryan Mischker 2.59 yrs

SBIO Net Fund Flows

1M 12.47M
3M 12.07M
6M 9.035M
YTD 12.47M
1Y 11.54M
3Y 151.71M
5Y --
10Y --
As of Jan. 31, 2018

SBIO Risk Info

Beta (5Y) 1.754
Max Drawdown (All) 49.69%
Historical Sharpe (10Y) --
Historical Sortino (All) 0.8051
30-Day Rolling Volatility 30.17%
Daily Value at Risk (VaR) 1% (All) 6.35%
Monthly Value at Risk (VaR) 1% (All) 26.84%

SBIO Fundamentals

Dividend Yield TTM (2-16-18) 0.00%
SEC Yield (1-31-18) -0.48%
Weighted Average PE Ratio --
Weighted Average Price to Sales Ratio 7.104
Weighted Average Price to Book Ratio 4.923
Weighted Median ROE -31.59%
Weighted Median ROA -27.63%
Forecasted Dividend Yield 0.01%
Forecasted PE Ratio 19.27
Forecasted Price to Sales Ratio 4.354
Forecasted Price to Book Ratio 3.151
Number of Holdings 97
As of Feb. 16, 2018

SBIO Growth Estimates

Forecasted 5 Yr Earnings Growth 31.43%
Forecasted Book Value Growth -3.19%
Forecasted Cash Flow Growth 1.86%
Forecasted Earnings Growth -4.98%
Forecasted Revenue Growth 4.54%
As of Feb. 16, 2018

SBIO Comparables

Edit

SBIO Attributes

Key Dates
Inception Date 12/30/2014
Termination Date
Last Annual Report Date 11/30/2017
Last Prospectus Date 3/31/2017
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

SBIO Excel Add-In Codes

  • Name: =YCI("SBIO","name")
  • Broad Asset Class: =YCI("SBIO", "broad_asset_class")
  • Broad Category: =YCI("SBIO", "broad_category_group")
  • Prospectus Objective: =YCI("SBIO", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.